Sir: The article by Szuba et al. was brought to my attention by a patient (a social worker) who had a hemorrhagic stroke after being switched from phenelzine to tranylcypromine. This patient remains significantly disabled from the sequelae of her stroke; she was previously described in one of the articles cited by Szuba et al. and was further described in a subsequent article by Gelenberg.
Save
Cite
Advertisement
GAM ID: sidebar-top